deoxycytidine and Precancerous Conditions

deoxycytidine has been researched along with Precancerous Conditions in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	1 (11.11)	18.2507
2000's	1 (11.11)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamada, S; Masamune, A; Shimosegawa, T; Taguchi, K; Yamamoto, M	1
Arlt, A; Deisinger, F; Helm, O; Hesse, L; Kha, ML; Röcken, C; Schäfer, H; Sebens, S; Sipos, B	1
Bendaoud, S; de Mestier, L; Hammel, P; Hentic, O; Lekhal, C; Neuzillet, C	1
Endrizzi, BT; Lee, PK	1
Favaudon, V; Fernet, M; Huguet, F; Monnier, L; Touboul, E	1
Schmutz, JL; Trechot, P	1
Cihák, A; Veselý, J	1
Bock, KW; Dirheimer, G; Keith, G; Münzel, PA; Pfohl-Leszkowicz, A; Röhrdanz, E	1
Farber, E; Ghoshal, A; Kanduc, D; Quagliariello, E	1

Reviews

2 review(s) available for deoxycytidine and Precancerous Conditions

Article	Year
[Pancreatic adenocarcinoma: 10 years of progress]. Bulletin du cancer, 2015, Volume: 102, Issue:6 Suppl 1 Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Induction Chemotherapy; Paclitaxel; Pancreatic Neoplasms; Precancerous Conditions	2015
[New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:5 Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Cystadenoma, Mucinous; Delayed Diagnosis; Deoxycytidine; Disease Progression; Gemcitabine; Genes, Tumor Suppressor; Humans; Intercellular Signaling Peptides and Proteins; Mutation; Neoplasm Proteins; Oncogenes; Pancreatic Neoplasms; Precancerous Conditions; Radiation Tolerance; Signal Transduction	2011

Article

Year

[Pancreatic adenocarcinoma: 10 years of progress].

Bulletin du cancer, 2015, Volume: 102, Issue:6 Suppl 1

Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Induction Chemotherapy; Paclitaxel; Pancreatic Neoplasms; Precancerous Conditions

2015

[New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:5

Topics: Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Cystadenoma, Mucinous; Delayed Diagnosis; Deoxycytidine; Disease Progression; Gemcitabine; Genes, Tumor Suppressor; Humans; Intercellular Signaling Peptides and Proteins; Mutation; Neoplasm Proteins; Oncogenes; Pancreatic Neoplasms; Precancerous Conditions; Radiation Tolerance; Signal Transduction

2011

Other Studies

7 other study(ies) available for deoxycytidine and Precancerous Conditions

Article	Year
Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis. Carcinogenesis, 2017, 06-01, Volume: 38, Issue:6 Topics: Animals; Carcinogenesis; Cell Line, Tumor; Deoxycytidine; Female; Gemcitabine; Genes, p53; Male; Mice; Mutation; NF-E2-Related Factor 2; Oxidative Stress; Pancreatic Neoplasms; Precancerous Conditions; Proto-Oncogene Proteins p21(ras)	2017
The antioxidant transcription factor Nrf2 modulates the stress response and phenotype of malignant as well as premalignant pancreatic ductal epithelial cells by inducing expression of the ATF3 splicing variant ΔZip2. Oncogene, 2019, Volume: 38, Issue:9 Topics: Activating Transcription Factor 3; Adenocarcinoma; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Epithelial Cells; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; NF-E2-Related Factor 2; Pancreatic Ducts; Precancerous Conditions; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays	2019
Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:10 Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Precancerous Conditions; Skin Neoplasms	2009
[Resolution of actinic keratosis with capecetabin]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Keratosis, Actinic; Male; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms	2012
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Cancer research, 1977, Volume: 37, Issue:10 Topics: Animals; Azacitidine; Deoxycytidine; Epithelium; Female; Leukemia L1210; Leukemia, Experimental; Liver; Lymph Nodes; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred DBA; Precancerous Conditions; Thymidine	1977
Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2 Topics: Animals; Deoxycytidine; DNA Modification Methylases; DNA, Bacterial; DNA, Neoplasm; Liver Neoplasms; Male; Methylation; Nitrosamines; Precancerous Conditions; Proto-Oncogenes; Rats; Rats, Inbred Strains; RNA, Neoplasm	1991
DNA hypomethylation in ethionine-induced rat preneoplastic hepatocyte nodules. Biochemical and biophysical research communications, 1988, Jan-29, Volume: 150, Issue:2 Topics: Animals; Deoxycytidine; DNA; Ethionine; Liver; Liver Neoplasms, Experimental; Male; Methylation; Precancerous Conditions; Rats; Rats, Inbred F344; Reference Values	1988